Balfaxar (Prothrombin Complex Concentrate (Human))
**Product type:** Plasma Derivative
**Active ingredient:** COAGULATION FACTOR IX HUMAN; COAGULATION FACTOR VII HUMAN; COAGULATION FACTOR X HUMAN; PROTEIN C; PROTEIN S HUMAN; PROTHROMBIN
**Strength:** 25.5; 16.5; 24; 22; 22; 26 [iU]/mL; [iU]/mL; [iU]/mL; [iU]/mL; [iU]/mL; [iU]/mL
**Dosage form:** Powder, For Solution
**Route:** Intravenous
**Labeler:** Octapharma USA Inc
**Marketing category:** BLA (BLA125776)
**Pharmacologic class:** Anti-coagulant [EPC], Blood Coagulation Factor [EPC], Blood Coagulation Factors [CS], Blood Coagulation Factors [CS], Blood Coagulation Factors [CS], Blood Coagulation Factors [CS], Decreased Coagulation Factor Activity [PE], Enzyme Precursors [CS], Human Blood Coagulation Factor [EPC], Human Blood Coagulation Factor [EPC], Human Blood Coagulation Factor [EPC], Increased Coagulation Activity [PE], Increased Coagulation Activity [PE], Increased Coagulation Activity [PE], Increased Coagulation Activity [PE], Protein C [CS]
/api/v1/systems/ndc_fda/nodes/68982-261Hierarchy Explorer
Cross-system equivalences0
No cross-system equivalences mapped for this node.